Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

University of Texas - M. D. Anderson Cancer Center

2 abstracts

Abstract
Uncovering mechanisms of response of pembrolizumab and lenvatinib for the treatment of platinum-resistant high grade serous ovarian cancer.
Org: University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Houston, University of Texas - M. D. Anderson Cancer Center,
Abstract
Phase II study of nivolumab (nivo) in combination with relatlimab (rela) in patients (pts) with active melanoma brain metastases (MBM).
Org: University of Texas MD Anderson Cancer Center, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Texas - M. D. Anderson Cancer Center, Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center,